Product Information

PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0965 per EA under NDC 16714064601. Its NADAC has been published 189 times since Apr 5, 2023.

FDA first approved this application on Feb 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 30 MG TABLET

Pioglitazone
$0.0965per EA

Strength

30 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714064601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202467

FDA Approved

2/6/2013

TE Code

AB

On Market Since

8/18/2022

Pharmacological Classes

PPAR alpha
PPAR gamma
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor Activity
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 189 times since Apr 5, 2023, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0965 per EA
All-time high$0.1233 (Jan 10, 2024)
All-time low$0.0828 (Nov 20, 2024)
52-week high$0.0974
52-week low$0.0888
Median price$0.0984
Average price$0.1025
Largest weekly change+24.7% (Jun 19, 2024)
Weeks tracked189
Tracking sinceApr 5, 2023

Price History

1W

0.0%

1M

+3.8%

3M

+6.8%

6M

+4.3%

1Y

-1.7%

3Y

-8.8%

5Y

N/A

All

-17.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0965 per EA (NDC 16714064601), effective Nov 11, 2026.

How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 17.1%. It has been tracked across 189 weekly CMS publications since Apr 5, 2023.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?

Since Apr 5, 2023, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.1233 (Jan 10, 2024), with a median of $0.0984 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 30 MG TABLET?

PIOGLITAZONE HCL 30 MG TABLET (NDC 16714064601) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.